MedDataX Logo

Implementation of a Novel Computerized Physician Order Entry System

NCT ID: NCT00713297

Last Updated: 2008-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-09-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this prospective study is to build a real-time interactive platform where doctors and pharmacists may communicate and solve patients' drug-related problems (DRP) immediately and document accordingly. This study will also design a computerized physician order entry (CPOE) system utilizing default protocol for chemotherapy order entry.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To err is human. Most errors are caused by problems in the system. Punishing health personnel cannot prevent the same mistakes. The only solution is a good medication system. CPOE system can prevent prescribing errors. The CPOE system is always the major step in some studies concerning reducing prescribing errors, dispensing errors or administering errors. In this user-friendly and convenient era, improvement in the CPOE system is an immediate need.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Computerized Physician Order Entry

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

medication errors computerized physician order entry pharmaceutical care chemotherapeutic agents reengineering

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observation

Those who will use the new CPOE system

satisfaction questionnaire

Intervention Type BEHAVIORAL

Satisfaction questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

satisfaction questionnaire

Satisfaction questionnaire

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

questionnaire

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* NTUH pharmacists

Exclusion Criteria

* NTUH pharmacists who have never recorded drug related problems
Minimum Eligible Age

24 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University

OTHER

Sponsor Role collaborator

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Pharmacy, N.T.U.H.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fe-Lin L. Wu, MSCP,Ph D

Role: PRINCIPAL_INVESTIGATOR

Department of Pharmacy, N.T.U.H.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fe-Lin L. Wu, MSCP,Ph D

Role: CONTACT

Phone: +886-2-23123456

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fe-Lin L Wu, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

200803060R

Identifier Type: -

Identifier Source: org_study_id